[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605247":3},{"organization":4,"outcomesModule":7,"designInfo":16,"detailedDescription":27,"studyPopulation":11,"armGroups":28,"interventions":39,"overallOfficials":45,"centralContacts":50,"locations":56,"responsibleParty":73,"collaborators":76,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":80,"sex":86,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":11,"studyType":92,"phases":93,"briefSummary":95,"conditions":96,"keywords":11,"overallStatus":58,"whyStopped":11,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Tianjin Medical University Eye Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"The density of cone cells",null,"From enrollment to the end of treatment at 3 weeks",[14],{"measure":15,"description":11,"timeFrame":12},"Repeatability of adaptive optics scanning laser ophthalmoscope technology of cone cell density",{"allocation":17,"interventionModel":18,"interventionModelDescription":11,"primaryPurpose":19,"observationalModel":11,"timePerspective":11,"maskingInfo":20},"NON_RANDOMIZED","PARALLEL","TREATMENT",{"masking":21,"maskingDescription":11,"whoMasked":22},"QUADRUPLE",[23,24,25,26],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR","This study focuses on the population with long-term use of repetitive low-intensity myopia, exploring the safety of repetitive low-intensity red light over a long period of use, and providing data support and clinical guidance for the field of repetitive low-intensity red light. It investigates the repeatability of adaptive optics scanning laser ophthalmoscope technology and observes the safety of repetitive low-intensity red light treatment for children over a long period of use.",[29,35],{"label":30,"type":31,"description":32,"interventionNames":33},"RLRL group","EXPERIMENTAL","Use RLRL (Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China)",[34],"Device: RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China))",{"label":36,"type":37,"description":38,"interventionNames":11},"No RLRL Group","NO_INTERVENTION","No use RLRL",[40],{"type":41,"name":42,"description":43,"armGroupLabels":44,"otherNames":11},"DEVICE","RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China))","use RLRL twice a day",[30],[46],{"name":47,"affiliation":48,"role":49},"Ruihua Wei","Tianjin Medical University Eye Hospital, Tianjin, Tianjin 120120 Recruiting","PRINCIPAL_INVESTIGATOR",[51],{"name":52,"role":53,"phone":54,"phoneExt":11,"email":55},"Guihua Liu","CONTACT","+8686428756","liuguihua1992@163.com",[57],{"facility":5,"status":58,"city":59,"state":60,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":69,"contacts":70},"RECRUITING","Tianjin","Tianjin Municipality","120120","China","CN",{"type":65,"coordinates":66},"Point",[67,68],117.17667,39.14222,{"lat":68,"lon":67},[71],{"name":52,"role":53,"phone":72,"phoneExt":11,"email":55},"8686428756",{"type":74,"investigatorFullName":47,"investigatorTitle":75,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"SPONSOR_INVESTIGATOR","Professor",[77],{"name":5,"class":6},"100605247","repeatability-of-ao-slo-mona-iia-technology-and-cone-cell-density-of-individuals-use-repeated-low-level-red-light-therapy-100605247",false,"NCT07160036","Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy","Exploring the Repeatability of Adaptive Optics Scanning Laser Ophthalmoscope Technology (AO-SLO Mona IIa) and the Differences in Cone Cell Density Between Individuals Who Undergone and Not Undergone Repeated Low-level Red-light","AO-SLO","Inclusion Criteria:\n\n* 6 - 55 years old, gender not limited; Obtained informed consent.\n\nExclusion Criteria:\n\n* Children with obvious strabismus and amblyopia\n* With congenital eye disease, such as congenital cataract, congenital retinal disease\n* Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)\n* Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)\n* Refractive medium opacity (such as corneal disease, crystal opacity, etc.)\n* Bnormal intraocular pressure and clinical significance (IOP \\\u003C10 mmHg or IOP\\>21mmHg or binocular IOP difference ≥5mmHg)\n* Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases\n* Optic nerve damage or congenital optic nerve dysfunction\n* Can not be regularly checked\n* The adjustment range is less than 8D or obvious near difficulties\n* Other reasons researchers think it is not suitable for inclusion in researchers","ALL","6 Years","55 Years",{"count":90,"type":91},180,"ESTIMATED","INTERVENTIONAL",[94],"NA","To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment",[97],"Myopia","2025-09-08",{"date":100,"type":101},"2025-09-15","ACTUAL",{"date":103,"type":91},"2025-09-20",{"date":105,"type":91},"2025-12-20",{"name":47,"class":6},1]